Since its discovery in 1910, sickle cell disease has been considered a death sentence for those that inherited it. But over the years, dedicated pediatric programs and research initiatives have greatly improved patient care ...
Sep 11, 2023
0
39
Scientists at St. Jude Children's Research Hospital found immune and tumor cells compete over glutamine, a major nutrient in their local environment, with significant implications for anti-cancer activity. If cancer cells ...
Jul 5, 2023
0
64
Sickle cell disease (SCD), a rare chronic, progressive, life-threatening, inherited blood disorder, often affects individuals with chronic pain that can be debilitating to their quality of life. Yet less than 4% of people ...
Mar 8, 2023
0
36
My husband did an excellent job carving our Thanksgiving turkey. So well, in fact, that very little was left on the bones that I typically use for making turkey soup. After simmering them overnight, however, I was surprised ...
Dec 2, 2022
0
70
Johns Hopkins Medicine researchers have revamped an anti-cancer drug to better target cancer cells and leave healthy tissues unharmed. Scientists have dubbed this type of targeted approach a "prodrug"—a medicine designed ...
Nov 16, 2022
0
1583
Improving knowledge of Schaaf-Yang syndrome (SYS), an ultra-rare disease caused by mutations in the MAGEL2 gene, is the aim of the first clinical guideline aimed at health care professionals and families of children affected ...
Oct 26, 2022
0
75
New research finds that glutamine, previously thought to help with burn injuries, does not improve patients' time to discharge from hospital.
Sep 27, 2022
0
33
